Patents by Inventor Simon Lucas

Simon Lucas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12110293
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: October 8, 2024
    Assignee: GRÜNENTHAL GMBH
    Inventors: Florian Jakob, Jo Alen, Simon Lucas, Tobias Craan, Ingo Konetzki, Achim Kless, Stefan Schunk, Paul Ratcliffe, Sebastian Wachten, Simon Cruwys
  • Publication number: 20240327416
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: May 14, 2024
    Publication date: October 3, 2024
    Inventors: Florian JAKOB, Jo ALEN, Simon LUCAS, Tobias CRAAN, Ingo KONETZKI, Achim KLESS, Stefan SCHUNK, Paul RATCLIFFE, Sebastian WACHTEN, Simon CRUWYS
  • Patent number: 11981677
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: May 14, 2024
    Assignee: Grünenthal GmbH
    Inventors: Florian Jakob, Jo Alen, Simon Lucas, Tobias Craan, Ingo Konetzki, Achim Kless, Stefan Schunk, Paul Ratcliffe, Sebastian Wachten, Simon Cruwys
  • Patent number: 11492104
    Abstract: A shimmy damper for centering a landing gear includes a cap and a housing. The shimmy damper further includes a damper shaft extending from the cap to the housing. The shimmy damper further includes a plurality of magnets configured to exert an opposing force on the cap and the housing via the damper shaft, providing a centering mechanism of the damper shaft within the housing. This centering action in turn provides for the centering of the landing gear during flight.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: November 8, 2022
    Assignee: GOODRICH CORPORATION
    Inventors: Bhuwan Jain, Simon Lucas, Benedict Sy
  • Publication number: 20210291967
    Abstract: A shimmy damper for centering a landing gear includes a cap and a housing. The shimmy damper further includes a damper shaft extending from the cap to the housing. The shimmy damper further includes a plurality of magnets configured to exert an opposing force on the cap and the housing via the damper shaft, providing a centering mechanism of the damper shaft within the housing. This centering action in turn provides for the centering of the landing gear during flight.
    Type: Application
    Filed: March 19, 2020
    Publication date: September 23, 2021
    Applicant: GOODRICH CORPORATION
    Inventors: BHUWAN JAIN, Simon Lucas, Benedict Sy
  • Publication number: 20210163491
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 3, 2021
    Applicant: Grünenthal GmbH
    Inventors: Florian JAKOB, Jo ALEN, Simon LUCAS, Tobias CRAAN, Ingo KONETZKI, Achim KLESS, Stefan SCHUNK, Paul RATCLIFFE, Sebastian WACHTEN, Simon CRUWYS
  • Publication number: 20210139488
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: January 20, 2021
    Publication date: May 13, 2021
    Applicant: GRÜNETHAL GMBH
    Inventors: Florian JAKOB, Jo ALEN, Simon LUCAS, Tobias CRAAN, Ingo KONETZKI, Achim KLESS, Stefan SCHUNK, Paul RATCLIFFE, Sebastian WACHTEN, Simon CRUWYS
  • Patent number: 10981918
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: April 20, 2021
    Assignee: GRÜNENTHAL GMBH
    Inventors: Florian Jakob, Jo Alen, Simon Lucas, Tobias Craan, Ingo Konetzki, Achim Kless, Stefan Schunk, Paul Ratcliffe, Sebastian Wachten, Simon Cruwys
  • Publication number: 20200024281
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: July 19, 2019
    Publication date: January 23, 2020
    Applicant: Grünenthal GmbH
    Inventors: Florian JAKOB, Jo ALEN, Simon LUCAS, Tobias CRAAN, Ingo KONETZKI, Achim KLESS, Stefan SCHUNK, Paul RATCLIFFE, Sebastian WACHTEN, Simon CRUWYS
  • Patent number: 10516705
    Abstract: Techniques for device control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and a remote device. The controller causes the remote device to initiate a communication session with a different device using a designated identity. The device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: December 24, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Publication number: 20180359289
    Abstract: Techniques for device control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and a remote device. The controller causes the remote device to initiate a communication session with a different device using a designated identity. The device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Application
    Filed: August 14, 2018
    Publication date: December 13, 2018
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Patent number: 10091252
    Abstract: Techniques for endpoint control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and an endpoint device. The controller then causes the endpoint device to initiate a communication session with a different endpoint device using an identity of the controller. The endpoint device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: October 2, 2018
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Patent number: 9775843
    Abstract: The invention relates to certain compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders that are, at least partially, mediated by TSPO activity.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: October 3, 2017
    Assignee: GRÜNENTHAL GMBH
    Inventors: Petra Bloms-Funke, Gregor Bahrenberg, Wolfgang Schröder, Sven Kühnert, Simon Lucas
  • Publication number: 20170273970
    Abstract: The invention relates to certain compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders that are, at least partially, mediated by TSPO activity.
    Type: Application
    Filed: June 14, 2017
    Publication date: September 28, 2017
    Applicant: GRÜNENTHAL GMBH
    Inventors: Petra BLOMS-FUNKE, Gregor Bahrenberg, Wolfgang Schröder, Sven Kühnert, Simon Lucas
  • Patent number: 9509741
    Abstract: Techniques for snapshot capture for a communication session are described. According to various embodiments, a communication session is established that includes a video feed that is streamed between devices involved in the communication session. The video feed is sampled to extract still images (e.g., frames) from the video feed that include images of a particular participant in the communication session. A snapshot is then selected from the images based on one or more selection criteria, such as an image score for the snapshot. Should a quality of the video feed fall below an acceptable video quality threshold during the communication session, the snapshot is used in place of the video feed for a visual representation of the participant during the communication session.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: November 29, 2016
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Publication number: 20160301727
    Abstract: Techniques for snapshot capture for a communication session are described. According to various embodiments, a communication session is established that includes a video feed that is streamed between devices involved in the communication session. The video feed is sampled to extract still images (e.g., frames) from the video feed that include images of a particular participant in the communication session. A snapshot is then selected from the images based on one or more selection criteria, such as an image score for the snapshot. Should a quality of the video feed fall below an acceptable video quality threshold during the communication session, the snapshot is used in place of the video feed for a visual representation of the participant during the communication session.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 13, 2016
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Publication number: 20160301719
    Abstract: Techniques for endpoint control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and an endpoint device. The controller then causes the endpoint device to initiate a communication session with a different endpoint device using an identity of the controller. The endpoint device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 13, 2016
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Patent number: 9284286
    Abstract: The invention relates to specific carboxamides, to processes for their preparation, to medicaments comprising these compounds and to the use of these compounds in the preparation of medicaments.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: March 15, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Simon Lucas, Sven Kühnert, Gregor Bahrenberg, Wolfgang Schröder
  • Patent number: 9278103
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: March 8, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • Patent number: 9248122
    Abstract: The invention relates to substituted heteroquinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: February 2, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Sven Kühnert, Simon Lucas, Gregor Bahrenberg, Wolfgang Schröder